Loading...
New

Patient Monitoring Devices Market by Product Type (Hemodynamic Monitoring, Neuromonitoring, Cardiac Monitoring, Fetal & Neonatal Monitoring, Respiratory Monitoring, Multi-Parameter Monitoring, Remote Patient Monitoring, Weigh Monitoring, And Temperature Monitoring Devices) and End User (Hospitals & Clinics, Home Settings, and Ambulatory Surgical Centers): Global Opportunity Analysis and Industry Forecast, 2020–2027

A01338
Pages: 319
Jul 2020 | 12819 Views
 
Author(s) : Kavita Joshi , Onkar Sumant
Tables: 133
Charts: 56
 

COVID-19

Pandemic disrupted the entire world and affected many industries.

Get detailed COVID-19 impact analysis on the Patient Monitoring Devices Market

Request Now !

The global patient monitoring devices market was $25,768.56 million in 2019, and is projected to reach $44,861.56 million by 2027 at a CAGR of 4.4% from 2020 to 2027. Patient monitoring systems are used to measure, record, distribute and display combinations of biometric values such as heart rate, blood oxygen saturation levels (SPO2), blood pressure, and temperature. They are used for monitoring patients regularly, which can help avoid serious problems. Furthermore, according to the IHS (Information Handling Services), more than four million patients are expected to monitor their health conditions remotely by 2020. This is a 34% increase in remote patient monitoring (RPM). Moreover, technological giants such as Google, Apple, and Amazon are tapping into the RPM market; which leads to drastic changes in healthcare.

Though most of the markets are dropping down, COVID-19 outbreak has positively affected various healthcare related markets, one of them being patient monitoring devices. At present, the patient monitoring devices market is witnessing a tremendous growth. As these are playing a crucial role to combat the pandemic and monitor patients. Patient monitoring devices including cardiac monitors, respiratory devices and temperature monitoring devices are facing a huge demand, owing to their immense usage in patient treatment.

Patient-Monitoring-Devices-Market-2020-2027

Get more information on this report : Request Sample Pages

 

The major factors that contribute toward the growth of the market include increase in geriatric population and rise in adoption of remote patient monitoring devices. In addition, surge in prevalence of patients suffering from different lifestyle diseases such as diabetes, cancer, and atherosclerosis also contribute toward uplifting growth of the patient monitoring devices market. Furthermore, collaborations between companies, hospitals, and academic institutions are expected to lead to the launch of new products, which would help to increase the market revenue and boost the market growth. However, cost associated with this technology and lack of awareness among patients hinder the market growth. Moreover, government regulations and reimbursement issues can also hamper growth of the patient monitoring devices market. 

Global Patient Monitoring Devices Market Segmentation  

The global patient monitoring devices market is segmented on the basis of product type, end user, and region. By product type, it is divided into hemodynamic monitoring, neuromonitoring, cardiac monitoring, fetal & neonatal monitoring, respiratory monitoring, multi-parameter monitoring, remote patient monitoring, weigh monitoring, and temperature monitoring devices. On the basis of end user it is segmented into hospitals, home settings, and ambulatory surgical centers. Region wise, the market is analyzed across North America, Europe, Asia-Pacific, and LAMEA. 

Segment Review

On the basis of product type, the cardiac monitoring devices segment dominated the patient monitoring devices market, governing around 26.08% of the global market value in 2019, and its dominance in the market is expected to continue throughout the forecast period. It is estimated to garner $10,256.24 million by 2027, registering a CAGR of 4.8% from 2020 to 2027. This is attributed to rise in prevalence of various cardiovascular diseases such as congestive heart failure and stroke each year across the globe. 

As remote patient monitoring devices can be used remotely to monitor critical parameters of patients, the segment is rapidly gaining popularity among patients with chronic diseases such as diabetes, hypertension, and chronic respiratory diseases. Thus, it is expected to be the fastest growing segment, registering a CAGR of 6.3% from 2020 to 2027

Patient Monitoring Devices Market
By Type

Your browser does not support the canvas element.

Remote Pateint Monitoring Devices holds the dominant position in 2019 and would continue to maintain the lead over the forecast period.

Get more information on this report : Request Sample Pages

By end user, the hospitals segment is expected to occupy majority of the market share, and is expected to retain its market position throughout the forecast period. Owing to the growth in awareness regarding advantages of using remote patient monitoring, the home setting segment is estimated to be the fastest growing segment, registering a CAGR of 5.0% during the forecast period. 

Patient Monitoring Devices Market
By End User

Your browser does not support the canvas element.

Home Setting segment is projected as one of the most lucrative segments.

Get more information on this report : Request Sample Pages

In 2019, North America and Europe were the most lucrative regions of the market, where growth is supplemented by factors such as rise in aging population, increase in prevalence and incidences of patients with lifestyle diseases, and well-established reimbursement policies along with high buying power of customers. The growth pattern in North America is characterized by the stage of market maturity, in terms of both penetration and availability of advanced devices. The Asia-Pacific patient monitoring devices market is estimated to account for the fastest growing subsegment globally.

Patient Monitoring Devices Market
By Region

2027
North America 
Europe
Asia-pacific
Lamea

Asia-Pacific region would exhibit the highest CAGR of 5.5% during 2019-2026.

Get more information on this report : Request Sample Pages

The global patient monitoring devices market is highly competitive, and prominent players have adopted various strategies for garnering maximum market share. These include collaboration, product launch, partnership, and acquisition. Major players operating in the market include Medtronic, Inc., Biotronik, F. Hoffmann-La Roche Ltd., GE Healthcare Ltd, Masimo Corporation, Nihon Kohden Corporation, Johnson and Johnson, Omron Healthcare Co. Ltd., Abbott Laboratories, and Koninklijke Philips N.V.

Key Benefits For Stakeholders

  • This report entails a detailed quantitative analysis along with the current and future global patient monitoring devices market trends from 2019 to 2027 to identify the prevailing opportunities along with the strategic assessment.
  • The patient monitoring devices market forecast is studied from 2019 to 2027. 
  • The market size and estimations are based on a comprehensive analysis of key developments in the industry.
  • A qualitative analysis based on innovative products facilitates strategic business planning.
  • The development strategies adopted by the key market players are enlisted to understand the competitive scenario of the market

Key Market Segments

By Product

  • Hemodynamic Monitoring Devices 
    • Blood Glucose
    • Cholesterol
    • Blood Gas & Electrolyte Analyzers/Monitors
    • Blood Pressure
  • Neuromonitoring Devices
    • Electroencephalograph (EEG) Devices
    • Transcranial Dopplers (TCD)
    • Magnetoencephalography (MEG) Devices
    • Intracranial Pressure Monitors (ICP)
    • Cerebral Oximeters
  • Cardiac Monitoring Devices
    • Electrocardiogram (ECG) Devices
    • Holter Monitor
    • Event Monitors
    • Others 
  • Fetal & Neonatal Monitoring Devices
    • Ultrasound 
    • Electronic Fetal Monitoring Devices
    • Fetal Doppler Monitoring Devices
    • Other Fetal & Neonatal Monitoring Devices
  •  Respiratory Monitoring Devices
    • Capnographs
    • Spirometers
    • Sleep Apnea Monitor
    • Pulse Oximeters
  • Multiparameter Monitoring Devices
    • High Acuity
    • Mid Acuity
    • Low Acuity
  • Remote Patient Monitoring Devices
  • Weight Monitoring Devices
  • Temperature Monitoring Devices

By End User

  • Hospitals & Clinics
  • Home Settings
  • Ambulatory Surgical Centers (ASCs)

By Region

  • North America
    • U.S.
    • Canada
    • Mexico
  • Europe
    • UK
    • Germany
    • France
    • Italy
    • Spain
    • Rest of Europe
  • Asia-Pacific
    • China
    • Japan
    • India
    • Australia
    • South Korea
    • Rest of Asia-Pacific
  • LAMEA
    • Brazil
    • Turkey
    • Venezuela
    • Saudi Arabia
    • Rest of LAMEA
 

CHAPTER 1:INTRODUCTION

1.1.Report description
1.2.Key benefits
1.3.Key market segments
1.4.Research methodology

1.4.1.Secondary research
1.4.2.Primary research
1.4.3.Analyst tools and models

CHAPTER 2:EXECUTIVE SUMMARY

2.1.CXO perspective

CHAPTER 3:MARKET OVERVIEW

3.1.Market definition and scope
3.2.Key findings

3.2.1.Top investment pockets
3.2.2.Top winning strategies

3.3.Top Player Positioning
3.4.Porter’s five forces analysis
3.5.COVID-19 impact on the market
3.6.Government regulations

3.6.1.U.S. FDA
3.6.2.European Conformity (CE) mark
3.6.3.Ministry of Health, Labor, and Welfare (MHLW)

3.7.Reimbursement scenarios
3.8.Clinical trials
3.9.Patent analysis

3.9.1.Patents Registered/Approved, 2011–2020
3.9.2.Patents Registered/Approved, by Applicants, 2011–2020

3.9.3.U.S. patent analysis, by market applicants
3.9.4.PCT patent analysis, by market applicants
3.9.5.Europe patent analysis, by market applicants
3.9.6.China patent analysis, by market applicants
3.9.7.Australia patent analysis by market applicants

3.10.Market Dynamics

3.10.1.Drivers

3.10.1.1.Rise in prevalence of lifestyle diseases
3.10.1.2.Increase in geriatric population
3.10.1.3.Rise in the adoption of remote patient monitoring devices

3.10.2.Restraints

3.10.2.1.Government regulations and reimbursement issues
3.10.2.2.Limited awareness and high costs

3.10.3.Opportunities

3.10.3.1.Untapped markets in developing countries
3.10.3.2.Technological advancements

CHAPTER 4:PATIENT MONITORING DEVICES MARKET, BY PRODUCT TYPE

4.1.Overview

4.1.1.Market size and forecast

4.2.Hemodynamic monitoring devices

4.2.1.Key market trends and opportunity
4.2.2.Market size and forecast
4.2.3.Market share analysis, by country
4.2.4.Blood glucose monitors

4.2.4.1.Market size and forecast

4.2.5.Blood gas and electrolyte analyzers/monitors

4.2.5.1.Market size and forecast

4.2.6.Blood pressure monitors

4.2.6.1.Market size and forecast

4.3.Neuromonitoring devices

4.3.1.Key market trends and opportunities
4.3.2.Market size and forecast
4.3.3.Market share analysis, by country
4.3.4.Electroencephalograph (EEG) devices

4.3.4.1.Market size and forecast

4.3.5.Transcranial dopplers (TCD)

4.3.5.1.Market size and forecast

4.3.6.Magnetoencephalograph (MEG) devices

4.3.6.1.Market size and forecast

4.3.7.Intracranial pressure monitors (ICP)

4.3.7.1.Market size and forecast

4.3.8.Cerebral oximeters

4.3.8.1.Market size and forecast

4.4.Cardiac monitoring devices

4.4.1.Key market trends and opportunities
4.4.2.Market size and forecast
4.4.3.Market share analysis, by country
4.4.4.Electrocardiogram (ECG) devices

4.4.4.1.By type
4.4.4.2.By lead type
4.4.4.3.Market size and forecast

4.4.5.Holter monitors

4.4.5.1.Market size and forecast

4.4.6.Event monitors

4.4.6.1.By type
4.4.6.2.By technology
4.4.6.3.Market size and forecast

4.4.7.Others (Implantable loop recorder, Cardiac output monitor and others)

4.4.7.1.Market size and forecast

4.5.Fetal neonatal monitoring devices

4.5.1.Key market trends and opportunities
4.5.2.Market size and forecast
4.5.3.Market share analysis, by country
4.5.4.Ultrasound

4.5.4.1.Market size and forecast

4.5.5.Electronic Fetal Monitoring Devices

4.5.5.1.Market size and forecast

4.5.6.Fetal Doppler Monitoring Devices

4.5.6.1.Market size and forecast

4.5.7.Others

4.5.7.1.Market size and forecast

4.6.Respiratory monitors

4.6.1.Key market trends and opportunities
4.6.2.Market size and forecast
4.6.3.Market share analysis, by country
4.6.4.Capnographs

4.6.4.1.Market size and forecast

4.6.5.Pulse oximeters

4.6.5.1.Market size and forecast

4.6.6.Sleep apnea monitors

4.6.6.1.Market size and forecast

4.6.7.Spirometers

4.6.7.1.Market size and forecast

4.7.Multiparameter monitoring devices

4.7.1.Key market trends and opportunities
4.7.2.Market size and forecast
4.7.3.Market share analysis, by country
4.7.4.High acuity

4.7.4.1.Market size and forecast

4.7.5.Mid acuity

4.7.5.1.Market size and forecast

4.7.6.Low acuity

4.7.6.1.Market size and forecast

4.8.Remote patient monitoring devices

4.8.1.Key market trends and opportunities
4.8.2.Market size and forecast
4.8.3.Market share analysis, by country

4.9.Weight monitoring devices

4.9.1.Key market trends and opportunities
4.9.2.Market size and forecast
4.9.3.Market share analysis, by country

4.10.Temperature monitoring devices

4.10.1.Key market trends and opportunities
4.10.2.Market size and forecast
4.10.3.Market share analysis, by country

4.11.Urine output monitoring

4.11.1.Key market trends and opportunities
4.11.2.Market size and forecast
4.11.3.Market share analysis, by country

CHAPTER 5:PATIENT MONITORING DEVICES MARKET, BY END USER

5.1.Overview

5.1.1.Market size and forecast

5.2.Hospitals

5.2.1.Market size and forecast
5.2.2.Market share analysis, by country

5.3.Home settings

5.3.1.Market size and forecast
5.3.2.Market share analysis, by country

5.4.Ambulatory surgical centers (ASCs)

5.4.1.Market size and forecast
5.4.2.Market share analysis, by country

CHAPTER 6:PATIENT MONITORING DEVICES MARKET, BY REGION

6.1.Overview

6.1.1.Market size and forecast

6.2.North America

6.2.1.Key opportunities and forecast
6.2.2.Market size and forecast

6.2.2.1.U.S. market size and forecast
6.2.2.2.Canada market size and forecast
6.2.2.3.Mexico market size and forecast

6.3.Europe

6.3.1.Key opportunities and forecast
6.3.2.Market size and forecast

6.3.2.1.Germany market size and forecast
6.3.2.2.France market size and forecast
6.3.2.3.UK market size and forecast
6.3.2.4.Italy market size and forecast
6.3.2.5.Spain market size and forecast
6.3.2.6.Rest of Europe market size and forecast

6.4.Asia-Pacific

6.4.1.Key opportunities and forecast
6.4.2.Market size and forecast

6.4.2.1.Japan market size and forecast
6.4.2.2.China market size and forecast
6.4.2.3.Australia market size and forecast
6.4.2.4.India market size and forecast
6.4.2.5.South Korea market size and forecast
6.4.2.6.Rest of Asia-Pacific market size and forecast

6.5.LAMEA

6.5.1.Key opportunities and forecast
6.5.2.Market size and forecast

6.5.2.1.Brazil market size and forecast
6.5.2.2.Turkey market size and forecast
6.5.2.3.Venezuela market size and forecast
6.5.2.4.Saudi Arabia market size and forecast
6.5.2.5.Rest of LAMEA market size and forecast

CHAPTER 7:COMPANY PROFILES

7.1.ABBOTT LABORATORIES

7.1.1.Company overview
7.1.2.Company snapshot
7.1.3.Operating business segments
7.1.4.Product portfolio
7.1.5.Business performance
7.1.6.Key strategic moves and developments

7.2.BIOTRONIK SE & CO. KG

7.2.1.Company overview
7.2.2.Company snapshot
7.2.3.Operating business segments
7.2.4.Product portfolio
7.2.5.Key strategic moves and developments

7.3.GENERAL ELECTRIC COMPANY (GE HEALTHCARE)

7.3.1.Company overview
7.3.2.Company snapshot
7.3.3.Operating business segments
7.3.4.Product portfolio
7.3.5.Business performance
7.3.6.Key strategic moves and developments

7.4.F. HOFFMANN-LA ROCHE LTD.

7.4.1.Company overview
7.4.2.Company snapshot
7.4.3.Operating business segments
7.4.4.Product portfolio
7.4.5.Business performance
7.4.6.Key strategic moves and developments

7.5.JOHNSON & JOHNSON

7.5.1.Company overview
7.5.2.Company snapshot
7.5.3.Operating business segments
7.5.4.Product portfolio
7.5.5.Business performance
7.5.6.Key strategic moves and developments

7.6.KONINKLIJKE PHILIPS N.V. (PHILIPS HEALTHCARE)

7.6.1.Company overview
7.6.2.Company snapshot
7.6.3.Operating business segments
7.6.4.Product portfolio
7.6.5.Business performance
7.6.6.Key strategic moves and developments

7.7.MASIMO CORPORATION

7.7.1.Company overview
7.7.2.Company snapshot
7.7.3.Product portfolio
7.7.4.Business performance
7.7.5.Key Strategic Moves and Developments

7.8.MEDTRONIC PLC.

7.8.1.Company overview
7.8.2.Company snapshot
7.8.3.Operating business segments
7.8.4.Medtronic offers following patient monitoring devices
7.8.5.Business performance
7.8.6.Key strategic moves and developments

7.9.NIHON KOHDEN CORPORATION

7.9.1.Company overview
7.9.2.Company snapshot
7.9.3.Operating business segments
7.9.4.Product portfolio
7.9.5.Business performance
7.9.6.Key strategic moves and developments

7.10.OMRON CORPORATION

7.10.1.Company overview
7.10.2.Company snapshot
7.10.3.Operating business segments
7.10.4.Product portfolio
7.10.5.Business performance
7.10.6.Key Strategic Moves and Development

LIST OF TABLES

TABLE 01.CLINICAL TRIALS: PATIENT MONITORING DEVICES MARKET, 2013–2020
TABLE 02.PATENTS REGISTERED/APPROVED ACROSS THE GLOBE, 2011–2020
TABLE 03.PATENTS REGISTERED/APPROVED, BY APPLICANTS, 2011–2020
TABLE 04.U.S. PATENT ANALYSIS, BY MARKET APPLICANTS, 2011- 2020
TABLE 05.PCT PATENT ANALYSIS, BY APPLICANTS, 2011–2020
TABLE 06.EUROPE PATENT ANALYSIS, BY MARKET APPLICANTS, 2011–2020
TABLE 07.CHINA PATENT ANALYSIS, BY MARKET APPLICANTS, 2011–2020
TABLE 08.AUSTRALIA PATENT ANALYSIS, BY MARKET APPLICANTS, 2011–2020
TABLE 09.GLOBAL PATIENT MONITORING DEVICES MARKET, BY PRODUCT TYPE, 2019–2027 ($MILLION)
TABLE 10.HEMODYNAMIC MONITORING DEVICES MARKET, BY TYPE, 2019–2027 ($MILLION)
TABLE 11.HEMODYNAMIC MONITORING DEVICES MARKET, BY REGION, 2019–2027 ($MILLION)
TABLE 12.BLOOD GLUCOSE MONITORING DEVICES MARKET, BY REGION, 2019–2027 ($MILLION)
TABLE 13.BLOOD GAS & ELECTROLYTE ANALYSERS MONITORING DEVICES MARKET, BY REGION, 2019–2027 ($MILLION)
TABLE 14.BLOOD PRESSURE MONITORING DEVICES MARKET, BY REGION, 2019–2027 ($MILLION)
TABLE 15.NEUROMONITORING DEVICES MARKET, BY TYPE, 2019–2027 ($MILLION)
TABLE 16.NEUROMONITORING DEVICES MARKET, BY REGION, 2019–2027 ($MILLION)
TABLE 17.ELECTROENCEPHALOGRAPH MONITORING DEVICES MARKET, BY REGION, 2019–2027 ($MILLION)
TABLE 18.TRANSCRANIAL DOPPLERS MONITORING DEVICES MARKET, BY REGION, 2019–2027 ($MILLION)
TABLE 19.MAGNETOENCEPHALOGRAPH MONITORING DEVICES MARKET, BY REGION, 2019–2027 ($MILLION)
TABLE 20.INTRACRANIAL PRESSURE MONITORING DEVICES MARKET, BY REGION, 2019–2027 ($MILLION)
TABLE 21.CEREBRAL OXIMETER MONITORING DEVICES MARKET, BY REGION, 2019–2027 ($MILLION)
TABLE 22.CARDIAC MONITORING DEVICES MARKET, BY TYPE, 2019–2027 ($MILLION)
TABLE 23.CARDIAC MONITORING DEVICES MARKET, BY REGION, 2019–2027 ($MILLION)
TABLE 24.ELECTROCARDIOGRAM MONITORING DEVICES MARKET, BY REGION, 2019–2027 ($MILLION)
TABLE 25.HOLTER MONITORING DEVICES MARKET, BY REGION, 2019–2027 ($MILLION)
TABLE 26.EVENT MONITORING DEVICES MARKET, BY REGION, 2019–2027 ($MILLION)
TABLE 27.OTHER CARDIAC MONITORING DEVICES MARKET, BY REGION, 2019–2027 ($MILLION)
TABLE 28.FETAL AND NEONATAL MONITORING DEVICES MARKET, BY TYPE, 2019–2027 ($MILLION)
TABLE 29.FETAL AND NEONATAL MONITORING DEVICES MARKET, BY REGION, 2019–2027 ($MILLION)
TABLE 30.ULTRASOUND MONITORING DEVICES MARKET, BY REGION, 2019–2027 ($MILLION)
TABLE 31.ELECTRONIC FETAL MONITORING DEVICES MARKET, BY REGION, 2019–2027 ($MILLION)
TABLE 32.FETAL DOPPLER MONITORING DEVICES MARKET, BY REGION, 2019–2027 ($MILLION)
TABLE 33.OTHER FETAL AND NEONATAL MONITORING DEVICES MARKET, BY REGION, 2019–2027 ($MILLION)
TABLE 34.RESPIRATORY MONITORING DEVICES MARKET, BY TYPE, 2019–2027 ($MILLION)
TABLE 35.RESPIRATORY MONITORING DEVICES MARKET, BY REGION, 2019–2027 ($MILLION)
TABLE 36.CAPNOGRAPH MONITORING DEVICES MARKET, BY REGION, 2019–2027 ($MILLION)
TABLE 37.PULSE OXIMETER MONITORING DEVICES MARKET, BY REGION, 2019–2027 ($MILLION)
TABLE 38.SLEEP APNEA MONITORING DEVICES MARKET, BY REGION, 2019–2027 ($MILLION)
TABLE 39.SPIROMETER MONITORING DEVICES MARKET, BY REGION, 2019–2027 ($MILLION)
TABLE 40.MULTIPARAMETER MONITORING DEVICES MARKET, BY TYPE, 2019–2027 ($MILLION)
TABLE 41.MULTIPARAMETER MONITORING DEVICES MARKET, BY REGION, 2019–2027 ($MILLION)
TABLE 42.HIGH ACUITY MULTIPARAMETER MONITORING DEVICES MARKET, BY REGION, 2019–2027 ($MILLION)
TABLE 43.MID ACUITY MULTIPARAMETER MONITORING DEVICES MARKET, BY REGION, 2019–2027 ($MILLION)
TABLE 44.LOW ACUITY MULTIPARAMETER MONITORING DEVICES MARKET, BY REGION, 2019–2027 ($MILLION)
TABLE 45.REMOTE PATIENT MONITORING DEVICES MARKET, BY REGION, 2019–2027 ($MILLION)
TABLE 46.WEIGHT MONITORING DEVICES MARKET, BY REGION, 2019–2027 ($MILLION)
TABLE 47.TEMPERATURE MONITORING DEVICES MARKET, BY REGION, 2019–2027 ($MILLION)
TABLE 48.PATIENT MONITORING DEVICES MARKET FOR URINE MONITORING DEVICES, BY REGION, 2019–2027 ($MILLION)
TABLE 49.GLOBAL PATIENT MONITORING DEVICES MARKET, BY END USER 2019–2027 ($MILLION)
TABLE 50.PATIENT MONITORING DEVICES MARKET IN HOSPITALS, BY REGION, 2019–2027 ($MILLION)
TABLE 51.PATIENT MONITORING DEVICES MARKET IN HOME SETTING, BY REGION, 2019–2027 ($MILLION)
TABLE 52.PATIENT MONITORING DEVICES MARKET IN AMBULATORY SURGICAL CENTERS, BY REGION, 2019–2027 ($MILLION)
TABLE 53.PATIENT MONITORING DEVICES MARKET, BY REGION, 2019–2027($MILLION)
TABLE 54.NORTH AMERICA PATIENT MONITORING DEVICES MARKET, BY PRODUCT TYPE, 2019–2027($MILLION)
TABLE 55.NORTH AMERICA PATIENT MONITORING DEVICES MARKET, BY END USER, 2019–2027($MILLION)
TABLE 56.NORTH AMERICA PATIENT MONITORING DEVICES MARKET, BY COUNTRY, 2019–2027($MILLION)
TABLE 57.U.S. PATIENT MONITORING DEVICES MARKET, BY PRODUCT TYPE, 2019–2027($MILLION)
TABLE 58.U.S. PATIENT MONITORING DEVICES MARKET, BY END USER, 2019–2027($MILLION)
TABLE 59.CANADA PATIENT MONITORING DEVICES MARKET, BY PRODUCT TYPE, 2019–2027($MILLION)
TABLE 60.CANADA PATIENT MONITORING DEVICES MARKET, BY END USER, 2019–2027($MILLION)
TABLE 61.MEXICO PATIENT MONITORING DEVICES MARKET, BY PRODUCT TYPE, 2019–2027($MILLION)
TABLE 62.MEXICO PATIENT MONITORING DEVICES MARKET, BY END USER, 2019–2027($MILLION)
TABLE 63.EUROPE PATIENT MONITORING DEVICES MARKET, BY PRODUCT TYPE, 2019–2027($MILLION)
TABLE 64.EUROPE PATIENT MONITORING DEVICES MARKET, BY END USER, 2019–2027($MILLION)
TABLE 65.EUROPE PATIENT MONITORING DEVICES MARKET, BY COUNTRY, 2019–2027($MILLION)
TABLE 66.GERMANY PATIENT MONITORING DEVICES MARKET, BY PRODUCT TYPE, 2019–2027($MILLION)
TABLE 67.GERMANY PATIENT MONITORING DEVICES MARKET, BY END USER, 2019–2027($MILLION)
TABLE 68.FRANCE PATIENT MONITORING DEVICES MARKET, BY PRODUCT TYPE, 2019–2027($MILLION)
TABLE 69.FRANCE PATIENT MONITORING DEVICES MARKET, BY END USER, 2019–2027($MILLION)
TABLE 70.UK PATIENT MONITORING DEVICES MARKET, BY PRODUCT TYPE, 2019–2027($MILLION)
TABLE 71.UK PATIENT MONITORING DEVICES MARKET, BY END USER, 2019–2027($MILLION)
TABLE 72.ITALY PATIENT MONITORING DEVICES MARKET, BY PRODUCT TYPE, 2019–2027($MILLION)
TABLE 73.ITALY PATIENT MONITORING DEVICES MARKET, BY END USER, 2019–2027($MILLION)
TABLE 74.SPAIN PATIENT MONITORING DEVICES MARKET, BY PRODUCT TYPE, 2019–2027($MILLION)
TABLE 75.SPAIN PATIENT MONITORING DEVICES MARKET, BY END USER, 2019–2027($MILLION)
TABLE 76.REST OF EUROPE PATIENT MONITORING DEVICES MARKET, BY PRODUCT TYPE, 2019–2027($MILLION)
TABLE 77.REST OF EUROPE PATIENT MONITORING DEVICES MARKET, BY END USER, 2019–2027($MILLION)
TABLE 78.ASIA-PACIFIC PATIENT MONITORING DEVICES MARKET, BY PRODUCT TYPE, 2019–2027($MILLION)
TABLE 79.ASIA-PACIFIC PATIENT MONITORING DEVICES MARKET, BY END USER, 2019–2027($MILLION)
TABLE 80.ASIA-PACIFIC PATIENT MONITORING DEVICES MARKET, BY COUNTRY, 2019–2027($MILLION)
TABLE 81.JAPAN PATIENT MONITORING DEVICES MARKET, BY PRODUCT TYPE, 2019–2027($MILLION)
TABLE 82.JAPAN PATIENT MONITORING DEVICES MARKET, BY END USER, 2019–2027($MILLION)
TABLE 83.CHINA PATIENT MONITORING DEVICES MARKET, BY PRODUCT TYPE, 2019–2027($MILLION)
TABLE 84.CHINA PATIENT MONITORING DEVICES MARKET, BY END USER, 2019–2027($MILLION)
TABLE 85.AUSTRALIA PATIENT MONITORING DEVICES MARKET, BY PRODUCT TYPE, 2019–2027($MILLION)
TABLE 86.AUSTRALIA PATIENT MONITORING DEVICES MARKET, BY END USER, 2019–2027($MILLION)
TABLE 87.INDIA PATIENT MONITORING DEVICES MARKET, BY PRODUCT TYPE, 2019–2027($MILLION)
TABLE 88.INDIA PATIENT MONITORING DEVICES MARKET, BY END USER, 2019–2027($MILLION)
TABLE 89.SOUTH KOREA PATIENT MONITORING DEVICES MARKET, BY PRODUCT TYPE, 2019–2027($MILLION)
TABLE 90.SOUTH KOREA PATIENT MONITORING DEVICES MARKET, BY END USER, 2019–2027($MILLION)
TABLE 91.REST OF ASIA-PACIFIC PATIENT MONITORING DEVICES MARKET, BY PRODUCT TYPE, 2019–2027($MILLION)
TABLE 92.REST OF ASIA-PACIFIC PATIENT MONITORING DEVICES MARKET, BY END USER, 2019–2027($MILLION)
TABLE 93.LAMEA PATIENT MONITORING DEVICES MARKET, BY PRODUCT TYPE, 2019–2027($MILLION)
TABLE 94.LAMEA PATIENT MONITORING DEVICES MARKET, BY END USER, 2019–2027($MILLION)
TABLE 95.LAMEA PATIENT MONITORING DEVICES MARKET, BY COUNTRY, 2019–2027($MILLION)
TABLE 96.BRAZIL PATIENT MONITORING DEVICES MARKET, BY PRODUCT TYPE, 2019–2027($MILLION)
TABLE 97.BRAZIL PATIENT MONITORING DEVICES MARKET, BY END USER, 2019–2027($MILLION)
TABLE 98.TURKEY PATIENT MONITORING DEVICES MARKET, BY PRODUCT TYPE, 2019–2027($MILLION)
TABLE 99.TURKEY PATIENT MONITORING DEVICES MARKET, BY END USER, 2019–2027($MILLION)
TABLE 100.VENEZUELA PATIENT MONITORING DEVICES MARKET, BY PRODUCT TYPE, 2019–2027($MILLION)
TABLE 101.VENEZUELA PATIENT MONITORING DEVICES MARKET, BY END USER, 2019–2027($MILLION)
TABLE 102.SAUDI ARABIA PATIENT MONITORING DEVICES MARKET, BY PRODUCT TYPE, 2019–2027($MILLION)
TABLE 103.SAUDI ARABIA PATIENT MONITORING DEVICES MARKET, BY END USER, 2019–2027($MILLION)
TABLE 104.REST OF LAMEA PATIENT MONITORING DEVICES MARKET, BY PRODUCT TYPE, 2019–2027($MILLION)
TABLE 105.REST OF LAMEA PATIENT MONITORING DEVICES MARKET, BY END USER, 2019–2027($MILLION)
TABLE 106.ABBOTT: COMPANY SNAPSHOT
TABLE 107.ABBOTT: OERATING SEGMENT
TABLE 108.ABBOTT: PRODUCT PORTFOLIO
TABLE 109.BIOTRONIK: COMPANY SNAPSHOT
TABLE 110.BIOTRONIK: OPERATING SEGMENTS
TABLE 111.BIOTRONIK: PRODUCT PORTFOLIO
TABLE 112.GE: COMPANY SNAPSHOT
TABLE 113.GE: OPERATING SEGMENTS
TABLE 114.GE: PRODUCT PORTFOLIO
TABLE 115.ROCHE: COMPANY SNAPSHOT
TABLE 116.ROCHE: OERATING SEGMENT
TABLE 117.ROCHE: PRODUCT PORTFOLIO
TABLE 118.J&J: COMPANY SNAPSHOT
TABLE 119.J&J: OPERATING SEGMENTS
TABLE 120.J&J: PRODUCT PORTFOLIO
TABLE 121.PHILIPS: COMPANY SNAPSHOT
TABLE 122.PHILIPS: OPERATING SEGMENTS
TABLE 123.PHILIPS: PRODUCT PORTFOLIO
TABLE 124.MASIMO: COMPANY SNAPSHOT
TABLE 125.MASIMO: PRODUCT PORTFOLIO
TABLE 126.MEDTRONIC: COMPANY SNAPSHOT
TABLE 127.MEDTRONIC: OPERATING BUSINESS SEGMENTS
TABLE 128.MEDTRONIC: PRODUCT PORTFOLIO
TABLE 129.NIHON KOHDEN CORPORATION: COMPANY SNAPSHOT
TABLE 130.GSK: PRODUCT PORTFOLIO
TABLE 131.OMRON CORPORATION: COMPANY SNAPSHOT
TABLE 132.OMRON CORPORATION: OPERATING SEGMENTS
TABLE 133.OMRON CORPORATION: PRODUCT PORTFOLIO

LIST OF FIGURES

FIGURE 01.TOP INVESTMENT POCKETS: GLOBAL PATIENT MONITORING DEVICES MARKET, BY DEVICE TYPE
FIGURE 02.TOP WINNING STRATEGIES, BY YEAR, 2017–2020*
FIGURE 03.TOP WINNING STRATEGIES, BY DEVELOPMENT, 2017–2020* (%)
FIGURE 04.TOP WINNING STRATEGIES, BY COMPANY, 2017–2020* (%)
FIGURE 05.TOP PLAYER POSITIONING
FIGURE 06.MODERATE BARGAINING POWER OF BUYERS
FIGURE 07.HIGH BARGAINING POWER OF SUPPLIERS
FIGURE 08.HIGH THREAT OF NEW ENTRANTS
FIGURE 09.MODERATE THREAT OF SUBSTITUTION
FIGURE 10.HIGH COMPETITIVE RIVALRY
FIGURE 11.PATENTS REGISTERED/APPROVED, 2011–2020
FIGURE 12.PATENTS REGISTERED/APPROVED, BY APPLICANTS, 2011–2020
FIGURE 13.U.S. PATENT ANALYSIS, BY MARKET APPLICANTS, 2011–2020
FIGURE 14.PCT PATENT ANALYSIS, BY MARKET APPLICANTS, 2011–2020
FIGURE 15.EUROPE PATENT ANALYSIS, BY MARKET APPLICANTS, 2011–2020
FIGURE 16.CHINA PATENT ANALYSIS, BY MARKET APPLICANTS, 2011–2020
FIGURE 17.AUSTRALIA PATENT ANALYSIS BY MARKET APPLICANTS, 2011–2020
FIGURE 18.COMPARATIVE SHARE ANALYSIS OF DELIVERY OF HEMODYNAMIC PATIENT MONTORING DEVICES MARKET, BY COUNTRY, 2019 & 2027(%)
FIGURE 19.COMPARATIVE SHARE ANALYSIS OF DELIVERY OF NEUROMONITORING PATIENT MONITORING DEVICES MARKET, BY COUNTRY, 2019 & 2027(%)
FIGURE 20.COMPARATIVE SHARE ANALYSIS OF DELIVERY OF CARDIAC PATIENT MONTORING DEVICES MARKET, BY COUNTRY, 2019 & 2027(%)
FIGURE 21.COMPARATIVE SHARE ANALYSIS OF DELIVERY OF FETAL AND NEONATAL MONITORING PATIENT MONITORING DEVICES MARKET, BY COUNTRY, 2019 & 2027(%)
FIGURE 22.COMPARATIVE SHARE ANALYSIS OF DELIVERY OF RESPIRATORY PATIENT MONITORING DEVICES MARKET, BY COUNTRY, 2019 & 2027(%)
FIGURE 23.COMPARATIVE SHARE ANALYSIS OF DELIVERY OF MULTIPARAMETER PATIENT MONITORING DEVICES MARKET, BY COUNTRY, 2019 & 2027(%)
FIGURE 24.COMPARATIVE SHARE ANALYSIS OF DELIVERY OF REMOTE PATEINT MONITORING DEVICES MARKET, BY COUNTRY, 2019 & 2027(%)
FIGURE 25.COMPARATIVE SHARE ANALYSIS OF DELIVERY OF WEIGHT PATIENT MONITORING DEVICES MARKET, BY COUNTRY, 2019 & 2027(%)
FIGURE 26.COMPARATIVE SHARE ANALYSIS OF DELIVERY OF TEMPERATURE PATIENT MONITORING DEVICES MARKET, BY COUNTRY, 2019 & 2027(%)
FIGURE 27.COMPARATIVE SHARE ANALYSIS OF DELIVERY OF URINE OUTPUT PATIENT MONITORING DEVICES MARKET, BY COUNTRY, 2019 & 2027(%)
FIGURE 28.COMPARATIVE SHARE ANALYSIS OF DELIVERY OF HOSPITAL PATIENT MONTORING DEVICES MARKET, BY COUNTRY, 2019 & 2027(%)
FIGURE 29.COMPARATIVE SHARE ANALYSIS OF DELIVERY OF HOME SETTINGS PATIENT MONTORING DEVICES MARKET, BY COUNTRY, 2019 & 2027(%)
FIGURE 30.COMPARATIVE SHARE ANALYSIS OF DELIVERY OF AMBULATORY SURGICAL CENTERS PATIENT MONTORING DEVICES MARKET, BY COUNTRY, 2019 & 2027(%)
FIGURE 31.ABBOTT: NET SALES, 2017–2019 ($MILLION)
FIGURE 32.ABBOTT: REVENUE SHARE, BY SEGMENT, 2019 (%)
FIGURE 33.ABBOTT: REVENUE SHARE, BY REGION, 2019 (%)
FIGURE 34.GE: NET SALES, 2017–2019 ($MILLION)
FIGURE 35.GE: REVENUE SHARE, BY SEGMENT, 2019 (%)
FIGURE 36.GE: REVENUE SHARE, BY REGION, 2019 (%)
FIGURE 37.ROCHE: NET SALES, 2017–2019 ($MILLION)
FIGURE 38.ROCHE: REVENUE SHARE, BY SEGMENT, 2019 (%)
FIGURE 39.ROCHE: REVENUE SHARE, BY REGION, 2019 (%)
FIGURE 40.J&J: NET SALES, 2017–2019 ($MILLION)
FIGURE 41.J&J: REVENUE SHARE, BY SEGMENT, 2019 (%)
FIGURE 42.J&J: REVENUE SHARE, BY REGION, 2019 (%)
FIGURE 43.PHILIPS: NET SALES, 2017–2019 ($MILLION)
FIGURE 44.PHILIPS: REVENUE SHARE, BY SEGMENT, 2019 (%)
FIGURE 45.PHILIPS: REVENUE SHARE, BY REGION, 2019(%)
FIGURE 46.MASIMO: NET SALES, 2017-2019 ($MILLION)
FIGURE 47.MASIMO: REVENUE SHARE, BY REGION, 2019 (%)
FIGURE 48.MEDTRONIC: NET SALES, 2017–2019 ($MILLION)
FIGURE 49.MEDTRONIC: REVENUE SHARE, BY SEGMENT, 2019 (%)
FIGURE 50.MEDTRONIC: REVENUE SHARE, BY REGION, 2019 (%)
FIGURE 51.NIHON KOHDEN: NET SALES, 2016–2018 ($MILLION)
FIGURE 52.NIHON KOHDEN: REVENUE SHARE, BY PRODUCT SEGMENT, 2018 (%)
FIGURE 53.NIHON KOHDEN: REVENUE SHARE, BY REGION, 2018 (%)
FIGURE 54.OMRON CORPORATION: NET SALES, 2016–2018 ($MILLION)
FIGURE 55.OMRON CORPORATION: REVENUE SHARE, BY SEGMENT, 2018 (%)
FIGURE 56.OMRON CORPORATION: REVENUE SHARE, BY REGION, 2018 (%)

 
 

Patient monitoring devices are used to monitor, measure, and record various physiological parameters of a patient. Owing to the rise in prevalence of various cardiac diseases, the market is dominated by the cardiac monitoring devices segment, which is expected to account for major revenue generation during the forecast period. The remote patient monitoring devices segment is estimated to be the fastest growing segment during the forecast period. This is mainly attributed to the growth in awareness about several benefits of using remote patient monitoring devices such as reduced hospital stay, improvement in clinical outcomes, and less number of hospital readmissions. Various advancements in the patient monitoring technology such as improvement in performance, utility, usability, & sensitivity, and decrease in size of the device are expected to boost the growth of the market. The untapped regions such as China and India are expected to emerge as lucrative markets, owing to growth in demand and awareness of patient monitoring devices. The growth of patient monitoring devices market is anticipated to largely be contributed by rise in incidences of lifestyle diseases and increase in the geriatric population.

The market is projected to gain traction in developing regions of Asia-Pacific, Africa, and Latin America. Large undiagnosed patient population, rapid urbanization, increase in disposable incomes, improved government funding toward healthcare, and growth in awareness about various lifestyle diseases are projected to contribute toward the market growth in these regions. However, pressing concerns related to cost of treatment are expected during the forecast period, especially in underdeveloped countries and developing countries such as India and China.


 

 

PURCHASE OPTIONS

Start reading instantly ,This title and over 12000 thousand more,available with Avenue Library,  T&C*

Reach out to us

Call us on
( U.S. - Canada toll free )
+1-800-792-5285,   
Int'l : +1-503-894-6022
( Europe )
+ 44-845-528-1300
Drop us an email at
help@alliedmarketresearch.com

 

HAVE QUESTIONS?
SPEAK WITH ANALYST

 

FREQUENTLY ASKED
QUESTIONS?

 

DID YOU MISS ANYTHING?
DO YOU HAVE SPECIFIC REQUIREMENTS?

 

Download Sample

OR

Purchase Full Report of
Patient Monitoring Devices Market

  • Online Only
  • $3,456
  • Online cloud access only
  • Restricted print, copy, paste & download
  • Read only
  •   Free quarterly industry update
  •   Free report update (Within 180 days)
  •   Subscription model sign in
  • Data Pack
  • $3,840
  • Restricted to one authorized user
  • One print only
  • Available in
    Excel
  •   Free quarterly industry update
  •   Free report update (Within 180 days)
  •   Subscription model sign in
  • Single User
  • $5,769
  • Restricted to one authorized user
  • One print only
  • Available in Excel & PDF
  •   Free quarterly industry update
  •   Free report update (Within 180 days)
  •   Subscription model sign in
  • Five Users
  • $6,450
  • Limited to five authorized users
  • Print upto five copies
  • Available in Excel & PDF
  •   Free quarterly industry update
  •   Free report update (Within 180 days)
  •   Subscription model sign in
  • Enterprise
    License/PDF

  • $8,995
  • Unlimited
    within
    company/enterprise
  • Available in Excel & PDF
  •   Free quarterly industry update
  •   Free report update (Within 180 days)
  •   Subscription model sign in
  • Library Membership
  • $ 699/mo
  • Published Content
    E-access
  • Company Profiles
    E-access
  • Newly Added Content Access
  • 10 PDF
    Downloads
  • 5 Excel Data
    Pack Downloads
  • 250 Company Profiles PDF Downloads
  • Start reading instantly.
    This title and over 12,000+ are available on the Avenue Library.  T&C*.

    Buy Now

*Taxes/Fees, if applicable will be added during checkout. All prices in USD

 

Why Allied Market Research?

 

Infallible Methodology

To ensure high-level data integrity, accurate analysis, and impeccable forecasts

Analyst Support

For complete satisfaction

Customization

On-demand customization of scope of the report to exactly meet your needs

TARGETED MARKET VIEW

Targeted market view to provide pertinent information and save time of readers

 
 

Featured Reports

 

Featured Readings

 

Get fresh content delivered

Get insights on topics that are crucial for your business. Stay abreast of your interest areas.

 
Get Industry Data Alerts